Deniega, Baby Boy .

HRN: 28-92-93  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
AMPICILLIN 250MG (VIAL)
05/08/2026
05/14/2026
IVT
205mg
Q12H
PSNB (Maternal UTI)
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines